Growth and Tolerance Trial on Infant Formula With HMO
Launched by FRIESLANDCAMPINA · Aug 22, 2019
Trial Information
Current as of June 13, 2025
Terminated
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Gestational age ≥ 37 weeks
- • Birth weight ≥ 2500 grams
- • No recognized diseases (such as cardiac, pulmonary, gastrointestinal, renal or genetic diseases)
- • Boys and girls
- • Recruited \< 1 month/age
- • Being available for follow up until the age of 4 months
- • Exclusive formula feeding or exclusive breast feeding at time of recruitment
- Exclusion Criteria:
- • Gestational age \<37 weeks
- • Birth weight \<2500 grams
- • Severe acquired or congenital diseases, mental or physical disorders
- • Illness at screening/ inclusion
- • Incapability of parents/caregivers to comply with the study protocol
- • Received antibiotics within the first month of life
- • Not tolerating standard cow's milk based infant formula
- • Participation in another clinical trial
- • Maternal illicit drug use during pregnancy or post-partum period
- • Parent/caregiver does not have a cell phone to use for filling out questionnaires
About Frieslandcampina
FrieslandCampina is a leading global dairy cooperative dedicated to enhancing the health and well-being of consumers through innovative dairy products and nutritional solutions. With a heritage rooted in centuries of dairy expertise, the organization prioritizes scientific research and development, driving advancements in nutrition and health-related clinical trials. Committed to sustainability and quality, FrieslandCampina collaborates with healthcare professionals and researchers to explore new frontiers in dairy nutrition, aiming to deliver products that support optimal health outcomes for individuals and communities worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cincinnati, Ohio, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials